Inactive Instrument

Chelsea Therapeutics International Ltd. Share Price

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson's Disease and Movement Disorders	12/14/12	GL
Chelsea Therapeutics : Newman Ferrara LLP : Announces Investigation of Chelsea Therapeutics International Ltd.	09/14/09	BU
Chelsea Therapeutics : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Chelsea Therapeutics International, Ltd. Stockholders	09/14/09	BU
Chelsea Therapeutics Joins NORD in Promoting Awareness for Rare Disease Day	28/14/28	GL
Chelsea Therapeutics International Ltd. : Chelsea Therapeutics Announces FDA Accelerated Approval of NORTHERA™ (Droxidopa) for the Treatment of Symptomatic NOH	19/14/19	PU

09/14/09

Sector

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+15.82%	121B
REGENERON PHARMACEUTICALS, INC.	+20.35%	113B
ARGENX SE	+17.47%	26.02B
BIONTECH SE	-25.31%	19.39B
GENMAB A/S	-19.51%	15.91B
BEIGENE, LTD.	-19.67%	15.09B
WUXI APPTEC CO., LTD.	-46.87%	15.06B
SAREPTA THERAPEUTICS, INC.	+62.55%	14.93B
NEUROCRINE BIOSCIENCES, INC.	+6.34%	13.85B